-
1
-
-
33744539999
-
The clomiphene citrate challenge test versus the exogenous follicle-stimulating hormone ovarian reserve test as a single test for identification of low responders and hyperresponders to in vitro fertilization
-
DOI 10.1016/j.fertnstert.2005.11.053, PII S0015028206003761
-
Kwee J, Schats R, McDonnell J, Schoemaker J, Lambalk CB. The Clomiphene Citrate Challenge Test (CCCT) versus the Exogenous Follicle stimulation hormone Ovarian Reserve Test (EFORT) as single test for identification of low and hyper responders to in vitro fertilization (IVF). Fertil Steril 2006;85:1714-1722 (Pubitemid 43816417)
-
(2006)
Fertility and Sterility
, vol.85
, Issue.6
, pp. 1714-1722
-
-
Kwee, J.1
Schats, R.2
McDonnell, J.3
Schoemaker, J.4
Lambalk, C.B.5
-
2
-
-
0028834945
-
Clinical evidence for a detrimental effect on uterine receptivity of high serum oestradiol concentrations in high and normal responder patients
-
Simon C, Cano F, Valbuena D, Remohi J, Pellicer A. Clinical evidence for a detrimental effect on uterine receptivity of high serum oestradiol concentrations in high and normal responder patients. Hum Reprod 1995;10:2432-2437
-
(1995)
Hum Reprod
, vol.10
, pp. 2432-2437
-
-
Simon, C.1
Cano, F.2
Valbuena, D.3
Remohi, J.4
Pellicer, A.5
-
3
-
-
0037383902
-
Bilateral partial oophorectomy in the management of severe ovarian hyperstimulation syndrome.An aggressive, but perhaps life-saving procedure
-
Amarin ZO. Bilateral partial oophorectomy in the management of severe ovarian hyperstimulation syndrome. An aggressive, but perhaps life-saving procedure. Hum Reprod 2003;18:659-664
-
(2003)
Hum Reprod
, vol.18
, pp. 659-664
-
-
Amarin, Z.O.1
-
4
-
-
33751247033
-
Low-dose dopamine agonist administration blocks vascular endothelial growth factor (VEGF)-mediated vascular hyperpermeability without altering VEGF receptor 2-dependent luteal angiogenesis in a rat ovarian hyperstimulation model
-
DOI 10.1210/en.2006-0657
-
Gómez R, González-Izquierdo M, Zimmermann RC, Novella-Maestre E, Alonso-Muriel I, Sanchez-Criado J, et al. Low-dose dopamine agonist administration blocks vascular endothelial growth factor (VEGF)- mediated vascular hyperpermeability without altering VEGF receptor 2-dependent luteal angiogenesis in a rat ovarian hyperstimulation model. Endocrinology 2006;147:5400-5411 (Pubitemid 44790595)
-
(2006)
Endocrinology
, vol.147
, Issue.11
, pp. 5400-5411
-
-
Gomez, R.1
Gonzalez-Izquierdo, M.2
Zimmermann, R.C.3
Novella-Maestre, E.4
Alonso-Muriel, I.5
Sanchez-Criado, J.6
Remohi, J.7
Simon, C.8
Pellicer, A.9
-
5
-
-
34547823052
-
Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction
-
DOI 10.1210/jc.2007-0409
-
Alvarez C, Martí-Bonmatí L, Novella-Maestre E, Sanz R, Gómez R, Fernández-Sánchez M, et al. Dopamine agonist Cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction. J Clin Endocrinol Metab 2007;92:2931-2937 (Pubitemid 47236352)
-
(2007)
Journal of Clinical Endocrinology and Metabolism
, vol.92
, Issue.8
, pp. 2931-2937
-
-
Alvarez, C.1
Marti-Bonmati, L.2
Novella-Maestre, E.3
Sanz, R.4
Gomez, R.5
Fernandez-Sanchez, M.6
Simon, C.7
Pellicer, A.8
-
7
-
-
0036865059
-
Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): A review
-
DOI 10.1093/humupd/8.6.559
-
Delvigne A, Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): A review. Hum Reprod Update 2002;8:559-577 (Pubitemid 35452781)
-
(2002)
Human Reproduction Update
, vol.8
, Issue.6
, pp. 559-577
-
-
Delvinge, A.1
Rozenberg, S.2
-
8
-
-
33645847254
-
Serum inhibin A,VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: A prospective randomized trial
-
Babayof R, Margalioth EJ, Huleihel M, Amash A, Zylber-Haran E, Gal M, et al. Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: A prospective randomized trial. Hum Reprod 2006;21:1260-1265
-
(2006)
Hum Reprod
, vol.21
, pp. 1260-1265
-
-
Babayof, R.1
Margalioth, E.J.2
Huleihel, M.3
Amash, A.4
Zylber-Haran, E.5
Gal, M.6
-
9
-
-
38049170879
-
The use of gonadotrophin-releasing hormone (9GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in highrisk patients undergoing in vitro fertilization syndrome: A prospective randomized controlled study
-
Engmann L, DiLuigi A, Schmidt D, Nulsen J, Maier D, Benadiva C. The use of gonadotrophin-releasing hormone (9GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in highrisk patients undergoing in vitro fertilization syndrome: A prospective randomized controlled study. Fertil Steril 2008;89:84-91.
-
(2008)
Fertil Steril
, vol.89
, pp. 84-91
-
-
Engmann, L.1
Diluigi, A.2
Schmidt, D.3
Nulsen, J.4
Maier, D.5
Benadiva, C.6
-
10
-
-
0028283354
-
Early and late presentation of the ovarian hyperstimulation syndrome: Two distinct entities with different risk factors
-
Lyons D, Wheeler CA, Frishman GN, Hackett RJ, Seifer DB, Haning RV. Early and late presentation of the ovarian hyperstimulation syndrome: Two distinct entities with different risk factors. Hum Reprod 1994;9:792-799
-
(1994)
Hum Reprod
, vol.9
, pp. 792-799
-
-
Lyons, D.1
Wheeler, C.A.2
Frishman, G.N.3
Hackett, R.J.4
Seifer, D.B.5
Haning, R.V.6
-
11
-
-
34247259868
-
Prevention and management of Ovarian Hyperstimulation Syndrome
-
DOI 10.1196/annals.1365.021, Women's Health and Disease: Gynecologic, Endocrine, and Reproductive Issues
-
Vlahos NF, Gregoriou O. Prevention and management of ovarian hyperstimulation syndrome. Ann N Y Acad Sci 2006;1092:247-264 (Pubitemid 47092342)
-
(2006)
Annals of the New York Academy of Sciences
, vol.1092
, pp. 247-264
-
-
Vlahos, N.F.1
Gregoriou, O.2
-
12
-
-
0036827816
-
Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade
-
DOI 10.1210/en.2002-220204
-
Gómez R, Simon C, Remohi J, Pellicer A. Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade. Endocrinology 2002;143:4339-4348 (Pubitemid 35239566)
-
(2002)
Endocrinology
, vol.143
, Issue.11
, pp. 4339-4348
-
-
Gomez, R.1
Simon, C.2
Remohi, J.3
Pellicer, A.4
-
13
-
-
0036259602
-
The role of endothelial cells in the pathogenesis of ovarian hyperstimulation syndrome
-
Albert C, Garrido N, Mercader A, Rao CV, Remohí J, Simón C, et al. The role of endothelial cells in the pathogenesis of ovarian hyperstimulation syndrome. Mol Hum Reprod 2002;8:409-418 (Pubitemid 34567918)
-
(2002)
Molecular Human Reproduction
, vol.8
, Issue.5
, pp. 409-418
-
-
Albert, C.1
Garrido, N.2
Mercader, A.3
Rao, C.V.4
Remohi, J.5
Simon, C.6
Pellicer, A.7
-
14
-
-
0014385194
-
Disappearance rate of endogenous luteinizing hormone and chorionic gonadotrophin in man
-
Yen SS, Llenera G, Little B, Pearson O. Disappearance rate of endogenous luteinizing hormone and chorionic gonadotrophin in man. J Clin Endocrinol Metab 1968;28:1763-1767
-
(1968)
J Clin Endocrinol Metab
, vol.28
, pp. 1763-1767
-
-
Yen, S.S.1
Llenera, G.2
Little, B.3
Pearson, O.4
-
15
-
-
0035793623
-
Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2): A reassessment using novel receptor-specific vascular endothelial growth factor mutants
-
DOI 10.1074/jbc.M002016200
-
Gille H, Kowalski J, Li B, LeCouter J, Moffat B, Ferrara N, et al. Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants. J Biol Chem 2001;276:3222-30. (Pubitemid 37411615)
-
(2001)
Journal of Biological Chemistry
, vol.276
, Issue.5
, pp. 3222-3230
-
-
Gille, H.1
Kowalski, J.2
Li, B.3
LeCouter, J.4
Moffat, B.5
Zioncheck, T.F.6
Pelletier, N.7
Ferrara, N.8
-
16
-
-
0041842763
-
Regulation of vascular permeability by vascular endothelial growth factors
-
DOI 10.1016/S1537-1891(03)00011-9
-
Bates DO, Harper SJ. Regulation of vascular permeability by vascular endothelial growth factors. Vascul Pharmacol 2002;39:225-237 (Pubitemid 37490748)
-
(2002)
Vascular Pharmacology
, vol.39
, Issue.4-5
, pp. 225-237
-
-
Bates, D.O.1
Harper, S.J.2
-
17
-
-
0037837014
-
Administration of moderate and high doses of gonadotropins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF receptor-2 expression that is associated to vascular hyperpermeability
-
DOI 10.1095/biolreprod.102.010801
-
Gómez R, Simón C, Remohí J, Pellicer A. Administration of moderate and high doses of gonadotrophins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF receptor-2 expression that is associated to vascular hyperpermeability. Biol Reprod 2003;68:2164-2171 (Pubitemid 36687009)
-
(2003)
Biology of Reproduction
, vol.68
, Issue.6
, pp. 2164-2171
-
-
Gomez, R.1
Simon, C.2
Remohi, J.3
Pellicer, A.4
-
18
-
-
0038327794
-
Efficacy and toxicity of the angiogenesis inhibitor SU5416 as a single agent in patients with advanced renal cell carcinoma, melanoma, and soft tissue sarcoma
-
Kuenen BC, Tabernero J, Baselga J, Cavalli F, Pfanner E, Conte PF, et al. Efficacy and toxicity of the angiogenesis inhibitor SU5416 as a single agent in patients with advanced renal cell carcinoma, melanoma, and soft tissue sarcoma. Clin Cancer Res 2003;9:1648-1655 (Pubitemid 36554587)
-
(2003)
Clinical Cancer Research
, vol.9
, Issue.5
, pp. 1648-1655
-
-
Kuenen, B.C.1
Tabernero, J.2
Baselga, J.3
Cavalli, F.4
Pfanner, E.5
Conte, P.F.6
Seeber, S.7
Madhusudan, S.8
Deplanque, G.9
Huisman, H.10
Scigalla, P.11
Hoekman, K.12
Harris, A.L.13
-
19
-
-
0035026748
-
The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor
-
DOI 10.1038/87895
-
Basu S, Nagy JA, Pal S, Vasile E, Eckelhoefer IA, Bliss VS, et al. The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor. Nat Med 2001;7:569-574 (Pubitemid 32448324)
-
(2001)
Nature Medicine
, vol.7
, Issue.5
, pp. 569-574
-
-
Basu, S.1
Nagy, J.A.2
Pal, S.3
Vasile, E.4
Eckelhoefer, I.A.5
Bliss, V.S.6
Manseau, E.J.7
Dasgupta, P.S.8
Dvorak, H.F.9
Mukhopadhyay, D.10
-
20
-
-
32044459380
-
Tyroxine hydroxylase (TH) downregulation in hyperstimulated ovaries reveals the dopamine agonist bromocriptine (Br2) as an effective and specific method to block increased vascular permeability (VP) in OHSS
-
Gomez R, Gonzalez-Izquierdo M, Simon C, Remohi J, Pellicer A. Tyroxine hydroxylase (TH) downregulation in hyperstimulated ovaries reveals the dopamine agonist bromocriptine (Br2) as an effective and specific method to block increased vascular permeability (VP) in OHSS. Fertil Steril 2003;80:43-44
-
(2003)
Fertil Steril
, vol.80
, pp. 43-44
-
-
Gomez, R.1
Gonzalez-Izquierdo, M.2
Simon, C.3
Remohi, J.4
Pellicer, A.5
-
21
-
-
40449100155
-
Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment: A pilot study
-
DOI 10.1093/humrep/dem315
-
Alvarez C, Alonso-Muriel I, García G, Crespo J, Bellver J, Simón C, et al. Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome (OHSS) in women undergoing ART. A pilot study. Hum Reprod 2007;22:3210-3214 (Pubitemid 351696781)
-
(2007)
Human Reproduction
, vol.22
, Issue.12
, pp. 3210-3214
-
-
Alvarez, C.1
Alonso-Muriel, I.2
Garcia, G.3
Crespo, J.4
Bellver, J.5
Simon, C.6
Pellicer, A.7
|